Connect with us

Published

on

The proliferation of weight-loss drugs like Ozempic is having an unintended side-effect on snack makers — a reduction in sales, according to a report.

Walmart said customers who have been taking the popular meds to slim down are cutting back on high-fat and salty treats because the weight-loss drugs help to suppress appetites.

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” John Furner, the CEO of Walmarts US operation, told Bloomberg.

Walmart, which sells weight-loss drugs at its pharmacies, is able to study changes in sales patterns using anonymized data on shopper populations, according to the outlet.

With those data sets, the Bentonville, Ark.-based can see how many customers are on diabetes-turned-weight-loss drugs like Ozempic, Wegovy, and Mounjaro and compare their shopping habits to those not taking the medications.

Furner said people on weight-loss drugs are purchasing “less units, slightly less calories,” but said that it’s too soon to conclude what effect the meds are having on Walmart’s overall sales.

Representatives for Walmart did not immediately respond to The Post’s request for comment.

One woman who takes Mounjaro said the reduction in appetite has cut her grocery bill by as much as 20%.

I still have a fully stocked kitchen, theres chips and pretzels in there. I dont find it tempting, Carolyn MacBain-Waldo told the Wall Street Journal.

Another Mounjaro user said she doesnt think about food all the time anymore and eats far fewer snacks.

The other day I had a single jelly bean, which is unheard of for me, Karyn Carlton, 47, told The Journal, adding that she also recently ordered a kids meal from a fast-food restaurant and felt satiated.

The drug, which stimulates the body to produce insulin and lowers blood sugar, has historically been used to treat Type 2 diabetes but was popularized after patients discovered their slimming effects, and particularly exploded when it was revealed celebrities like Khloe Kardashian and Chelsea Handler admitted to using it.

Their use has filtered to middle America and is only expected to grow, despite disturbing case studies where the medications paralyzed some users’ stomachs and even burned off one woman’s genitals.

Morgan Stanley estimated that 7% of the US population, or 24 million people, will be taking hunger-suppressing weight-loss drugs by 2035 — cutting their daily calorie consumption by as much as 30%, according to the firm, which surveyed over 300 patients.

For a person on an FDA-recommended 2,000-calorie daily diet, that could mean eliminating a one-ounce bag of salted potato chips, a bottle of soda, and more each day.

“The food, beverage, and restaurant industries could see softer demand, particularly for unhealthier foods and high-fat, sweet, and salty options, said Morgan Stanleys tobacco and packaged food analyst Pamela Kaufman.

Kaufman said major food companies like Conagra Brands, Mondelez, and Campbell Soup could see a 3% hit to their bottom lines by 2035.

Kellogg’s Brands, which is behind popular snack foods like Cheez-Its and Pringles, has reportedly been studying the potential impact popular weight-loss drugs could have on consumer behaviors.

“Like everything that potentially impacts our business, well look at it, study it and, if necessary, mitigate,” Kellogg’s chief Steve Cahillane told Bloomberg.

Cahillane called it “very, very early days” for the drugs, but said the company, which also makes Rice Krispie Treats, was “by no means complacent,” suggesting Kellogg’s would make changes to its products if overweight Americans on weight-loss medications continued limiting their calorie intake.

The Post has sought comment from Kellogg’s.

Despite being “early days,” US sales for GLP-1-containing drugs have experienced a whopping 300% increase in prescription volume from 2020 to 2022, according to Trilliant Health.

Of those prescriptions, Ozempic was the most-prescribed GLP-1, and national spending on semaglutide — the peptide name for Ozempic and Wegovy — now exceeds $10 billion, Trilliant Health said.

Continue Reading

Environment

Rare earth stocks surge on U.S-China trade dispute over the critical minerals

Published

on

By

Rare earth stocks surge on U.S-China trade dispute over the critical minerals

A dump truck moves raw ore inside the pit at the Mountain Pass mine, operated by MP Materials, in Mountain Pass, California, U.S., on Friday, June 7, 2019.

Joe Buglewicz | Bloomberg | Getty Images

Shares of U.S. rare earth miners surged in early trading Monday, after President Donald Trump threatened China with retaliation over its strict export controls.

USA Rare Earth soared more than 18%, Critical Metals surged 18%, Energy Fuels jumped more than 11%, and MP Materials rallied about 8%.

Trump on Friday threatened China with a “massive” increase in tariffs in retaliation for Beijing imposing strict export controls on rare earth elements. The president then dialed down his rhetoric on Sunday, saying the situation with China will “be fine.”

The Defense Department, meanwhile, is accelerating its effort to stockpile $1 billion worth of critical minerals, according to The Financial Times.

And JPMorgan Chase said Monday it would invest up to $10 billion in companies that are crucial to U.S. national security.

“It has become painfully clear that the United States has allowed itself to become too reliant on unreliable sources of critical minerals, products and manufacturing — all of which are essential for our national security,” JPMorgan CEO Jamie Dimon said in press release.

Rare earths are a subset of critical minerals that are crucial inputs in U.S. weapons platforms, robotics, electric vehicles and other applications.

Continue Reading

Environment

Bloom Energy shares soar more than 30% after striking deal with Brookfield to provide fuel cells to AI data centers

Published

on

By

Bloom Energy shares soar more than 30% after striking deal with Brookfield to provide fuel cells to AI data centers

Bloom Energy power storage equipment in San Ramon, California.

Smith Collection | Gado | Archive Photos | Getty Images

Shares of Bloom Energy surged Monday after striking a deal with Brookfield to deploy fuel cells for artificial intelligence data centers.

Brookfield will spend up to $5 billion to deploy Bloom Energy’s technology, the first investment in its strategy to support big AI data centers with power and computing infrastructure.

Shares of Bloom Energy were up more than 30% in early trading. Bloom’s fuel cells provide onsite power that can be deployed quickly because they do not rely on the electric grid.

Nvidia CEO Jensen Huang told CNBC last week that the AI industry will need to build power off the electric to meet demand quickly and protect consumers from rising electricity prices.

“Data center self-generated power could move a lot faster than putting it on the grid and we have to do that,” Huang told CNBC on Oct. 8.

This is breaking news. Please refresh for updates.

Continue Reading

Environment

JPMorgan Chase says it will invest $10 billion into industries critical for national security

Published

on

By

JPMorgan Chase says it will invest  billion into industries critical for national security

JPMorgan Chase says it will invest $10 billion into industries critical for national security

JPMorgan Chase on Monday said it is launching a decade-long plan to help finance and take direct stakes in companies it considers crucial to U.S. interests.

The bank said in a statement it would invest up to $10 billion into companies in four areas: defense and aerospace, “frontier” technologies including AI and quantum computing, energy technology including batteries, and supply chain and advanced manufacturing.

The money is part of a broader effort, dubbed the Security and Resiliency Initiative, in which JPMorgan said it will finance or facilitate $1.5 trillion in funding for companies it identifies as crucial. It said the total amount is 50% more than a previous plan.

“It has become painfully clear that the United States has allowed itself to become too reliant on unreliable sources of critical minerals, products and manufacturing — all of which are essential for our national security,” JPMorgan CEO Jamie Dimon said in the release.

As the biggest American bank by assets and a Wall Street juggernaut, JPMorgan was already raising funds and lending money to companies in those industries. But the move helps organize the company’s activities around national interests at a time of heightened tensions between the U.S. and China.

On Friday, markets tumbled as President Donald Trump announced new tariffs on Chinese imports after the major U.S. trading partner tightened export controls on rare earths.

In the release, Dimon said that the U.S. needs to “remove obstacles” including excessive regulations, “bureaucratic delay” and “partisan gridlock.”

JPMorgan said that within the four major areas, there were 27 specific industries it would look to support with advice, financing and investments. That includes areas as diverse as nanomaterials, autonomous robots, spacecraft and space launches, and nuclear and solar power.

“Our security is predicated on the strength and resiliency of America’s economy,” Dimon said. “This new initiative includes efforts like ensuring reliable access to life-saving medicines and critical minerals, defending our nation, building energy systems to meet AI-driven demand and advancing technologies like semiconductors and data centers.”

The bank said it would hire an unspecified numbers of bankers and create an external advisory council to support its initiative.

This story is developing. Please check back for updates.

Continue Reading

Trending